Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

AEC Substrate Buffer, 10X

5.0(1)
Write a reviewAsk a question

See product citations (4)

Application:
AEC Substrate Buffer, 10X is a 10X buffer diluent for use with AEC. For use in HRP-based detection systems
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

AEC (3-Amino-9-ethylcarbazole) Substrate Buffer, 10X is a specialized solution used primarily in immunohistochemistry and in situ hybridization techniques for chromogenic detection of antigens. This buffer serves as a crucial component in the substrate solution for the AEC chromogen, which, when used with a corresponding enzyme-conjugated antibody (typically horseradish peroxidase or HRP), results in a visible, bright red precipitate at the site of the target antigen. The mechanism of action for AEC involves the enzymatic conversion by HRP, where AEC acts as a hydrogen donor in the presence of hydrogen peroxide, leading to the formation of a red azo compound that is insoluble in water and alcohol, thereby localizing the stain to the area where the enzyme is active. The 10X concentration of the buffer allows for easy dilution and optimal pH adjustment, ensuring that the enzymatic activity is at its peak and the staining reaction is efficient. In research, this buffer system and staining method are extensively used to visualize cell and tissue antigens under a microscope, providing crucial insights into tissue architecture and cellular function, especially in fields like pathology and cell biology. The use of AEC Substrate Buffer facilitates the precise and localized detection of specific proteins, aiding in the diagnosis and study of various diseases at the molecular level without altering the morphology of the tissues being examined.


AEC Substrate Buffer, 10X References

  1. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses.  |  Schiött, A., et al. 2011. Int J Pharm. 414: 312-20. PMID: 21601626
  2. A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.  |  Chattopadhyay, A., et al. 2013. J Virol. 87: 395-402. PMID: 23077320
  3. Quantitative measurement of iNOS expression in melanoma, nasopharyngeal, colorectal, and breast tumors of Tunisian patients: comparative study and clinical significance.  |  Dabbeche-Bouricha, E., et al. 2016. Tumour Biol. 37: 5153-64. PMID: 26547585
  4. Immunohistochemical examination in arthrofibrosis of the knee joint.  |  Mayr, HO., et al. 2019. Arch Orthop Trauma Surg. 139: 383-391. PMID: 30656476
  5. Targeting Anthrax Toxin Receptor 2 Ameliorates Endometriosis Progression.  |  Lin, SC., et al. 2019. Theranostics. 9: 620-632. PMID: 30809297
  6. Development of a blocking immunoperoxidase monolayer assay for differentiation between pseudorabies virus-infected and vaccinated animalss.  |  Wang, YB., et al. 2019. Pol J Vet Sci. 22: 717-723. PMID: 31867929
  7. Glial Cell Line-Derived Neurotrophic Factor, S-100 Protein and Synaptophysin Expression in Biliary Atresia Gallbladder Tissue.  |  Gürünlüoğlu, S., et al. 2021. Pediatr Gastroenterol Hepatol Nutr. 24: 173-186. PMID: 33833973
  8. Evaluation of the Delivery of a Live Attenuated Porcine Reproductive and Respiratory Syndrome Virus as a Unit Solid Dose Injectable Vaccine.  |  Hayhurst, E., et al. 2022. Vaccines (Basel). 10: PMID: 36366345
  9. Targeting YAP1 ameliorates progesterone resistance in endometriosis.  |  Lin, SC., et al. 2023. Hum Reprod. 38: 1124-1134. PMID: 37071897
  10. Potential mechanisms mediating PM2.5-induced alterations of H3N2 influenza virus infection and cytokine production in human bronchial epithelial cells.  |  Wang, Y., et al. 2023. Ecotoxicol Environ Saf. 259: 115069. PMID: 37244199

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

AEC Substrate Buffer, 10X, 50 ml

sc-36873
50 ml
$179.00